2D Radiotherapy Field Borders for Supraglottic Cancer
For supraglottic carcinoma treated with 2D radiotherapy, field margins should be 1.5-2 cm beyond the gross tumor volume for tumors >2 cm, and 1-1.5 cm for smaller lesions, with field sizes generally larger than 7×7 cm to adequately cover bilateral cervical lymphatics at risk. 1, 2
Field Size and Margin Recommendations
Primary Tumor Coverage
- Tumors <2 cm: Use 1-1.5 cm field margins around the gross tumor volume 1
- Tumors ≥2 cm: Use 1.5-2 cm field margins around the gross tumor volume 1
- Minimum field size: Fields smaller than 7×7 cm result in significantly higher neck failure rates (18% vs 3%, p=0.00005), particularly in early-stage disease 2
Critical Anatomic Considerations
- Superior border: Must include the base of tongue and valleculae, as the tongue base-supraglottic complex develops from one central embryologic region 3
- Inferior border: Should extend to cover the supraglottic larynx adequately 4
- Lateral borders: Must encompass bilateral cervical lymphatics, as supraglottic tumors have bilateral lymphatic drainage patterns 5
Nodal Coverage Requirements
Bilateral Neck Treatment
- Bilateral neck irradiation is mandatory for supraglottic carcinomas due to high risk of bilateral nodal involvement (44% incidence in clinically N0 patients) 5
- Field size significantly impacts regional control: larger fields (>7×7 cm) reduce neck failure from 18% to 3% 2
- Even in clinically N0 necks, 30% harbor occult metastases, with 100% involving level II and 82% involving level I nodes 5
Specific Nodal Levels
- Levels I-IV must be included bilaterally in the radiation field for adequate coverage of regions at highest risk 5
- The submandibular triangle (level I) and upper jugular nodes (level II) are consistently involved and require coverage 5
Dose Considerations
Primary Site Dosing
- T1-T2 lesions: 50-55 Gy in conventional fractionation (1.8-2.0 Gy per fraction) 1, 2
- T3-T4 lesions: 66-70 Gy for definitive treatment 1
- No significant dose-response relationship exists over the range of 1650-2300 ret for supraglottic cancer 2
Regional Nodal Dosing
- Clinically negative but at-risk nodes: 50 Gy over 5 weeks 1
- Clinically evident adenopathy: 66-70 Gy over 6.6-7 weeks 1
Critical Pitfalls to Avoid
Field Size Errors
- Avoid undersized fields: The most common technical error is using fields <7×7 cm, which dramatically increases neck failure rates from 3% to 18% 2
- This applies particularly to early-stage disease where the temptation to use smaller fields is greatest 2
Inadequate Nodal Coverage
- Do not treat unilaterally: Even for lateralized tumors, bilateral neck treatment is required due to the 44% bilateral involvement rate 5
- Include level I nodes: Failure to include the submandibular triangle results in inadequate coverage, as 82% of occult disease involves this level 5
Treatment Outcomes by Stage
Local Control Rates with Adequate Fields
- T1: 92-100% local control 4, 6
- T2: 80-88% local control 4, 6
- T3: 68-79% local control 4, 6
- T4: 56% local control 4, 6
Regional Control
- N1 disease: 71% control 4
- N2 disease: 38% control 4
- N3 disease: 25% control 4
- Preoperative radiotherapy with radical neck dissection prevents recurrence in the dissected neck 4
Technical Setup Parameters
Beam Arrangement
- Use opposed lateral fields (AP-PA or lateral-lateral technique) for 2D planning 1
- Megavoltage photons with energies of 4-6 MV are recommended 1
- All fields should be treated daily, 5 days per week 1